Genepath Diagnostics India Private Limited, a active private limited company, was established on 29 January 2019 in Pune, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U74999PN2019PTC181759. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹10.00 K .
It upholds a compliant status. Employing 52 professional, Its leadership includes Nikhil Dileep Phadke (Director), Christopher Leigh Kolenaty (Director). Past directors included Sangeeta Dileep Phadke, Christopher Leigh Kolenaty. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4Th Floor, Above Phadke Hospital, 1260/B, J M Road, Shivajinagar,, Pune, Maharashtra, 411004.
U74999PN2019PTC181759
181759
29 January 2019
₹1.00 M
₹10.00 K
Roc Pune
Unlisted
Active
Explore comprehensive insights into Genepath Diagnostics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Dileep Phadke | Director | 29 Jan 2019 | Current |
| Christopher Leigh Kolenaty | Director | 11 Apr 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genepath Diagnostics India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 80.88% increase. The company also saw a substantial fall in profitability, with a 40.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 130.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Genepath Diagnostics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Genepath Diagnostics India has a workforce of 52 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genepath Diagnostics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genepath Diagnostics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Genepath Diagnostics India Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was completed.
Progress on Genepath Diagnostics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
Progress on Christopher Leigh Kolenaty was appointed as a Director was appointed as a Director on 11 Apr 2019 & has been associated with this company since 6 years 7 months . was documented.
Nikhil Dileep Phadke was appointed as a Director was appointed as a Director on 29 Jan 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
The activity Genepath Diagnostics India Private Limited was registered on 29 Jan 2019 with Roc Pune & aged 6 years 9 months as per MCA records. was completed.
The CIN of Genepath Diagnostics India Private Limited is U74999PN2019PTC181759.
Genepath Diagnostics India Private Limited is headquartered at 4Th Floor, Above Phadke Hospital, 1260/B, J M Road, Shivajinagar,, Pune, Maharashtra, 411004.
Genepath Diagnostics India Private Limited was incorporated on 29 January 2019.
The current directors of Genepath Diagnostics India Private Limited are
The primary industry of Genepath Diagnostics India Private Limited is Hospital And Medical Care.
Genepath Diagnostics India Private Limited is unlisted.
The authorized capital of Genepath Diagnostics India Private Limited is ₹1.00 M, and the paid-up capital is ₹10.00 K .
The compliance status of Genepath Diagnostics India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX